» Articles » PMID: 14754416

Self-assembling Nucleic Acid Delivery Vehicles Via Linear, Water-soluble, Cyclodextrin-containing Polymers

Overview
Journal Curr Med Chem
Specialty Chemistry
Date 2004 Feb 3
PMID 14754416
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Non-viral (synthetic) nucleic acid delivery systems have the potential to provide for the practical application of nucleic acid-based therapeutics. We have designed and prepared a tunable, non-viral nucleic acid delivery system that self-assembles with nucleic acids and centers around a new class of polymeric materials; namely, linear, water-soluble cyclodextrin-containing polymers. The relationships between polymer structure and gene delivery are illustrated, and the roles of the cyclodextrin moieties for minimizing toxicity and forming inclusion complexes in the self-assembly processes are highlighted. This vehicle is the first example of a polymer-based gene delivery system formed entirely by self-assembly.

Citing Articles

Recent Advances in the Pharmaceutical and Biomedical Applications of Cyclodextrin-Capped Gold Nanoparticles.

Abdellatif A, Ahmed F, Mohammed A, Alsharidah M, Al-Subaiyel A, Samman W Int J Nanomedicine. 2023; 18:3247-3281.

PMID: 37337575 PMC: 10277008. DOI: 10.2147/IJN.S405964.


Targeting DAMPs with nucleic acid scavengers to treat lupus.

Olson L, Hunter N, Rempel R, Sullenger B Transl Res. 2022; 245:30-40.

PMID: 35245691 PMC: 9167234. DOI: 10.1016/j.trsl.2022.02.007.


β-Cyclodextrin-containing polymer treatment of cutaneous lupus and influenza improves outcomes.

Kelly L, Olson L, Rempel R, Everitt J, LeVine D, Nair S Mol Ther. 2021; 30(2):845-854.

PMID: 34628051 PMC: 8821959. DOI: 10.1016/j.ymthe.2021.10.003.


Curcumin Encapsulated in Crosslinked Cyclodextrin Nanoparticles Enables Immediate Inhibition of Cell Growth and Efficient Killing of Cancer Cells.

Moller K, Macaulay B, Bein T Nanomaterials (Basel). 2021; 11(2).

PMID: 33672006 PMC: 7919290. DOI: 10.3390/nano11020489.


Polymer nanomedicines.

Kopecek J, Yang J Adv Drug Deliv Rev. 2020; 156:40-64.

PMID: 32735811 PMC: 7736172. DOI: 10.1016/j.addr.2020.07.020.